News By Tag
* Infant Mortality Rates
* More Tags...
News By Location
Developed nations that require the most infant vaccines tend to have the highest infant death rate
The infant mortality rate (IMR) is one of the most important indicators of public health. The US childhood immunization schedule specifies 26 vaccine doses for infants aged less than 1 year—the most in the world—yet 33 nations have lower IMRs.
The current study by Miller and Goldman, “Infant Mortality Rates Regressed Against Number of Vaccine Doses Routinely Given: Is There a Biochemical or Synergistic Toxicity?” (available online), found “a high statistically significant correlation between increasing number of vaccine doses and increasing infant mortality rates.” This raises an important question: Would fewer vaccines administered to infants reduce the number of infant deaths? The authors concluded that “closer inspection of correlations between vaccine doses, biochemical or synergistic toxicity, and infant mortality rates, is essential. All nations — rich and poor, advanced and developing — have an obligation to determine whether their immunization schedules are achieving their desired goals.”
Other study findings:
The United States spends more per capita on healthcare than any other country yet 33 nations have better infant mortality rates.
Some infant deaths attributed to sudden infant death syndrome (SIDS) may be vaccine-related, perhaps due to over-vaccination.
Progress on reducing infant deaths should include monitoring immunization schedules and official causes of death (to determine if vaccine-related infant deaths are being reclassified)
Infant mortality rates will remain high in developing nations that cannot provide clean water, proper nutrition, improved sanitation, and better access to health care.
Download the entire study here. (http://het.sagepub.com/
Hum Exp Toxicol published online 4 May 2011. DOI: 10.1177/0960327111407644
The study’s authors can be contacted as follows: Neil Z. Miller: neilzmiller@
Gary S. Goldman: pearblossominc@
# # #
Gary S. Goldman, Ph.D., Computer Scientist, served for eight years, from January 1995 until October of 2002, as Research Analyst for the Antelope Valley Varicella Active Surveillance Project i(VASP), in cooperation with the Los Angeles County Department of Health (Acute Communicable Disease Control Unit--ACDC) funded by the Centers for Disease Control and Prevention (CDC, Atlanta, GA). He has served as a reviewer for the Journal of the American Medical Association (JAMA), Vaccine, The American Journal of Managed Care (AJMC), Expert Review of Vaccines (ERV), Expert Review of Dermatology (ERD), Journal of the European Academy of Dermatology and Venereology (JEADV), Epidemiology and Infection, and British Medical Journal (BMJ). He is included on the Editorial Board of Research and Reviews in BioSciences. He shares authorship and co-authorship on other recent peer-reviewed publications. From 1978-80 he instructed graduate and undergraduate courses at Calif. State Univ. at Fullerton.
Page Updated Last on: May 21, 2011